AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Arvinas to Present at Upcoming Investor Conferences
ByAinvest
Friday, Aug 29, 2025 7:03 am ET1min read
Arvinas, a clinical-stage biotechnology company, announced that management will participate in fireside chats at two upcoming investor conferences: Wells Fargo Healthcare Conference and Cantor Global Healthcare Conference. The events will be webcast live on the company's website. Arvinas is developing protein degradation therapies using its PROTAC platform for diseases such as breast cancer, non-Hodgkin lymphoma, and neurodegenerative disorders.
Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company focused on developing targeted protein degradation therapies, announced that management will participate in fireside chats at two upcoming investor conferences. The events, scheduled for September 4 and 5, include the Wells Fargo Healthcare Conference and the Cantor Global Healthcare Conference, respectively. Live audio webcasts of both presentations will be accessible through the company's website under the "Events and Presentations" section of the Investors and Media page.Arvinas is dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. The company's PROTAC (PROteolysis TArgeting Chimera) protein degrader platform aims to harness the body's natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; ARV-102, targeting LRRK2 for neurodegenerative disorders; and ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic and colorectal cancers.
References:
[1] https://www.globenewswire.com/news-release/2025/08/29/3141410/0/en/Arvinas-to-Participate-in-Upcoming-Investor-Conferences.html
[2] https://www.stocktitan.net/news/ARVN/arvinas-to-participate-in-upcoming-investor-n1atndee88b7.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet